Attorney Eric L. Young Represents Whistleblower Oswald Bilotta in One of the Largest Ever Recoveries in a Health Care Fraud Case Brought Under the Qui Tam Provisions of the False Claims Act PHILADELPHIA, July 01, 2020 (GLOBE NEWSWIRE) — Attorney Eric. L. Young announced today that Novartis Pharmaceuticals Corporation (“Novartis”) has agreed to settle alleged […]
Other News
Dr. David G. Kallend joins DalCor Pharmaceuticals as Chief Scientific Officer
LONDON and MONTREAL, July 02, 2020 (GLOBE NEWSWIRE) — DalCor Pharmaceuticals today announced the appointment of Dr. David G. Kallend as Chief Scientific Officer effective July 1, 2020. Dr. Kallend joins DalCor from The Medicines Company where he held the position of Senior Vice President and Chief Medical Officer. He […]
Sofinnova Partners Announces Two First Investments from its MD Start III Medtech Acceleration Fund
Investments in innovative medical devices follow the fund’s initial closing in May 2019 PARIS–(BUSINESS WIRE)–Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today the second investment from its MD Start III Fund, a medtech accelerator that actively works with clinicians and […]
Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist
DANVERS, Mass.–(BUSINESS WIRE)–The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist, finds 84% of the patients survived to explant with 76% native heart recovery. The study was published in the July edition of the American Society for Artificial Internal Organs (ASAIO) Journal. The study examined […]
Mpirik Adds Renowned Cardiothoracic Surgeon, Dr. Daniel O’Hair, As Its Chief Medical Officer
MILWAUKEE, July 1, 2020 /PRNewswire/ — Mpirik, an A.I. healthcare technology company that develops automated patient screening models for cardiovascular disease to drive actionable knowledge, quality and research, has named Dr. Daniel O’Hair as its Chief Medical Officer. For more than 20 years Dr. Daniel O’Hair has practiced as a Cardiovascular Surgeon, thought leader and scientific innovator […]
Mentice Appoints Thanos Karras as Americas General Manager to Accelerate Group’s Growth Strategy
GOTHENBURG, Sweden, July 1, 2020 /PRNewswire/ — Mentice AB (STO: MNTC) today announced the appointment of Thanos Karras as the company’s new General Manager for Americas. Thanos’ appointment will play a critical role in supporting Mentice’s continual growth strategy and will help accelerate its leadership position in high fidelity endovascular simulation solutions. Vice President […]
Society for Vascular Surgery (SVS) Issues Guidance on Competence Recommendations for TCAR
New Guidelines Consistent with Silk Road Medical Certification Process SUNNYVALE, Calif., June 30, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the In-Press release of a clinical competence statement on training and credentialing for TransCarotid […]
BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors
Former President and CEO of the North American division of AstraZeneca Plc to join as Independent Director Westport, CT, July 01, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity […]
Esperion Announces Publication in the Journal of the American Medical Association Cardiology of Pooled Efficacy Analysis from the Phase 3 LDL-C Lowering Clinical Development Program of NEXLETOL® (bempedoic acid) Tablets
ANN ARBOR, Mich., July 01, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that pooled efficacy analysis from the four Phase 3 clinical studies of NEXLETOL, an oral, once-daily LDL-cholesterol lowering medicine, was published in the Journal of the American Medical Association (JAMA) Cardiology. The four Phase 3 clinical studies […]
Matinas BioPharma Resumes Enrollment in the ENHANCE-IT and EnACT Clinical Trials
– Topline data from ENHANCE-IT study of MAT9001 vs. Vascepa® expected in Q1 2021 – – EnACT remains on track for cohort progression in Q4 2020 – BEDMINSTER, N.J., June 30, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has commenced enrollment and started dosing […]
Recent
Anaxiom Announces Early Clinical Results from First-in-Human Experience of Novel Minimally Invasive Obesity Device; Advances Toward U.S. Early Feasibility Study
NEW STUDY LINKS GLP-1 MEDICATIONS TO LOWER RISK OF ATRIAL FIBRILLATION, INDEPENDENT OF WEIGHT LOSS
Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation
Popular
- No commented posts yet